RECRUITINGINTERVENTIONAL
PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"
About This Trial
This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age ≥ 18 years
- Thyroidectomy or bilateral thyroid resection of any indication
- Written willing to sign a consent form obtained after detailed patient information and provision of an information sheet
Who Should NOT Join This Trial:
- Age ≤ 18 years
- Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause)
- Previous surgery in the neck region
- Pregnancy or breastfeeding
- Inability to attend study visits
- Participation in another study that interferes with the endpoints
- Missing or inadequate patient information
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age ≥ 18 years
* Thyroidectomy or bilateral thyroid resection of any indication
* Written informed consent obtained after detailed patient information and provision of an information sheet
Exclusion Criteria:
* Age ≤ 18 years
* Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause)
* Previous surgery in the neck region
* Pregnancy or breastfeeding
* Inability to attend study visits
* Participation in another study that interferes with the endpoints
* Missing or inadequate patient information
Treatments Being Tested
DRUG
Active vitamin D
Application if parathyroid hormone level falls below normal
DRUG
Calcium
Administered if parathyroid hormone level falls below normal
Locations (1)
Dept. Surgery I; University Hospital Wuerzburg
Würzburg, Bavaria, Germany